The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meluleni, G. J.
Right arrow Articles by Pier, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meluleni, G. J.
Right arrow Articles by Pier, G. B.

The Journal of Immunology, Vol 155, Issue 4 2029-2038, Copyright © 1995 by American Association of Immunologists

ARTICLES

Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients

GJ Meluleni, M Grout, DJ Evans and GB Pier
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Serum opsonophagocytic-killing titers often indicate the level of immune resistance to bacterial pathogens, yet in almost all cystic fibrosis (CF) patients that have chronic lung infections with mucoid Pseudomonas aeruginosa, high titers of opsonic-killing Abs can be measured and the infectious pathology still progresses through pulmonary failure and death. This anomalous finding may be due to the use of suspended cells of P. aeruginosa to evaluate phagocytic killing, whereas in the lungs of CF patients the organisms grow in a microcolony or biofilm, encased in mucoid exopolysaccharide (MEP, also called alginate). To determine whether the microcolony mode of growth contributes to bacterial resistance to host defenses, we evaluated opsonophagocytic killing of mucoid P. aeruginosa growing in a biofilm. Abs from infected CF patients were poorly able to mediate opsonic killing of biofilm, but not suspended, mucoid P. aeruginosa cells. Bacterial resistance to killing could be overcome by disruption of the biofilm layer with an enzyme that degrades MEP. Chronically infected CF patients also fail to produce opsonic-killing Abs specific to MEP, and when these Abs were evaluated in sera of older, noninfected CF patients and humans vaccinated with MEP, comparable killing of P. aeruginosa in biofilms and suspensions was obtained. In this case, C3 was deposited onto the MEP layer and could be visualized by fluorescence microscopy deposited throughout the biofilm. We conclude that opsonic Abs made by CF patients in response to chronic infection are ineffective at mediating phagocytic killing and elimination of bacterial cells growing as microcolonies in their lungs.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
S. Fuschillo, A. De Felice, and G. Balzano
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Eur. Respir. J., February 1, 2008; 31(2): 396 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Cerca, K. K. Jefferson, R. Oliveira, G. B. Pier, and J. Azeredo
Comparative Antibody-Mediated Phagocytosis of Staphylococcus epidermidis Cells Grown in a Biofilm or in the Planktonic State.
Infect. Immun., August 1, 2006; 74(8): 4849 - 4855.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. Zolfaghar, D. J. Evans, R. Ronaghi, and S. M. J. Fleiszig
Type III Secretion-Dependent Modulation of Innate Immunity as One of Multiple Factors Regulated by Pseudomonas aeruginosa RetS
Infect. Immun., July 1, 2006; 74(7): 3880 - 3889.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. G. Leid, C. J. Willson, M. E. Shirtliff, D. J. Hassett, M. R. Parsek, and A. K. Jeffers
The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-{gamma}-Mediated Macrophage Killing
J. Immunol., December 1, 2005; 175(11): 7512 - 7518.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. Sarkisova, M. A. Patrauchan, D. Berglund, D. E. Nivens, and M. J. Franklin
Calcium-Induced Virulence Factors Associated with the Extracellular Matrix of Mucoid Pseudomonas aeruginosa Biofilms
J. Bacteriol., July 1, 2005; 187(13): 4327 - 4337.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Hoffmann, T. B. Rasmussen, P. Jensen, C. Stub, M. Hentzer, S. Molin, O. Ciofu, M. Givskov, H. K. Johansen, and N. Hoiby
Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis
Infect. Immun., April 1, 2005; 73(4): 2504 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. B. Pier, D. Boyer, M. Preston, F. T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G. P. Priebe, et al.
Human Monoclonal Antibodies to Pseudomonas aeruginosa Alginate That Protect against Infection by Both Mucoid and Nonmucoid Strains
J. Immunol., November 1, 2004; 173(9): 5671 - 5678.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. C. Wolfgang, J. Jyot, A. L. Goodman, R. Ramphal, and S. Lory
Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients
PNAS, April 27, 2004; 101(17): 6664 - 6668.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Theilacker, F. T. Coleman, S. Mueschenborn, N. Llosa, M. Grout, and G. B. Pier
Construction and Characterization of a Pseudomonas aeruginosa Mucoid Exopolysaccharide-Alginate Conjugate Vaccine
Infect. Immun., July 1, 2003; 71(7): 3875 - 3884.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
N. Bomchil, P. Watnick, and R. Kolter
Identification and Characterization of a Vibrio cholerae Gene, mbaA, Involved in Maintenance of Biofilm Architecture
J. Bacteriol., February 15, 2003; 185(4): 1384 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
J. L. Martinez and F. Baquero
Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance
Clin. Microbiol. Rev., October 1, 2002; 15(4): 647 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. M. Donlan and J. W. Costerton
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Clin. Microbiol. Rev., April 1, 2002; 15(2): 167 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
J. B. Lyczak, C. L. Cannon, and G. B. Pier
Lung Infections Associated with Cystic Fibrosis
Clin. Microbiol. Rev., April 1, 2002; 15(2): 194 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
M. Hentzer, G. M. Teitzel, G. J. Balzer, A. Heydorn, S. Molin, M. Givskov, and M. R. Parsek
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
J. Bacteriol., September 15, 2001; 183(18): 5395 - 5401.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. B. Pier, F. Coleman, M. Grout, M. Franklin, and D. E. Ohman
Role of Alginate O Acetylation in Resistance of Mucoid Pseudomonas aeruginosa to Opsonic Phagocytosis
Infect. Immun., March 1, 2001; 69(3): 1895 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. A. Hatch and N. L. Schiller
Alginate Lyase Promotes Diffusion of Aminoglycosides through the Extracellular Polysaccharide of Mucoid Pseudomonas aeruginosa
Antimicrob. Agents Chemother., April 1, 1998; 42(4): 974 - 977.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.